Home › Guides › Process Conditions to Set for TFF Concentration and Buffer Exchange

Process Conditions to Set for TFF Concentration and Buffer Exchange

In the TFF (tangential flow filtration) step after purification, you need to set the membrane molecular weight cut-off, operating pressure (TMP) and crossflow rate, the number of buffer exchanges (diavolumes), the concentration at which to exchange, and the final volume and recovery method. We have also summarized, from public sources, how pH and excipients can drift from target at high concentration, and how to check membrane cleaning and reuse.

Filtration & Separation · Published 2026.11.09 · Last reviewed 2026.11.09

What TFF Concentration and Buffer Exchange Do

In TFF, ultrafiltration (UF) removes solvent and small molecules through the membrane to concentrate the product, and diafiltration (DF) adds new buffer as the permeate leaves to exchange the buffer.[9][10] In biopharmaceutical processes, this step usually follows purification and sets the final formulation concentration and buffer.[12][14]

Choosing the Membrane: Cut-off and Format

  • The general rule is to choose a molecular weight cut-off (MWCO) 3 to 6 times smaller than the molecular weight of the molecule to be retained.[5][6][7] For concentration only, the 3X end is usually enough; with extensive buffer exchange, a tighter membrane toward the 6X end is safer.[5][7]
  • Molecular weight is only a rough guide. Passage depends on shape, charge and buffer conditions, so confirm retention with your actual product.[5][8]
  • Membranes come as flat-sheet cassettes and hollow fibers. Rather than assuming hollow fibers are always gentler, some recommend testing product quality under your actual flow and channel conditions.[21][22]

Operating Pressure (TMP) and Crossflow

As TMP rises, permeate flux first increases with it, but beyond a certain point it barely increases.[1][3] Raising pressure further in this region increases the protein concentration at the membrane surface and the risk of fouling and yield loss.[1][2] The operating point is therefore set with a TMP excursion test, measuring flux at different TMPs for each crossflow rate.[1][2] Because viscosity rises as concentration proceeds and changes flux and pressure, check again at the final concentration and in the new buffer.[2][4]

Number of Diavolumes and Diafiltration Concentration

A diavolume (DV) is the volume of new buffer added divided by the product volume at that time. In constant-volume diafiltration, a freely permeating substance theoretically falls as C/C0 = e^(-N), so about 0.7% remains after 5 DV.[9] In practice, poor mixing, partial retention by the membrane and binding to the protein mean less is removed, so measure what remains and set the number of diavolumes from that.[9][10]

You also need to choose the concentration at which to diafilter. When dilute, flux is high but volume is large; when concentrated, less buffer is needed but flux is low, so there is an optimum concentration in between.[1][11]

pH and Excipient Shifts at High Concentration, and Final Volume

  • When concentrating to high levels, charged buffer components (for example histidine) can be pushed away from the protein (the Donnan effect), so the pH and excipient levels in the final product may differ from the buffer you added.[12][13][14] For this reason, the concentration or pH of the diafiltration buffer is sometimes adjusted in advance.[12][14]
  • Hold-up volume in the system affects how much you recover, and minimum working volume (MWV) limits how far you can concentrate.[15][16][17] Flushing with buffer at the end increases recovery but dilutes the product, so decide how far to over-concentrate beyond the target to allow for this.[15][16]
  • Single-pass TFF (SPTFF), which concentrates in one pass without recirculation, is studied and used to connect continuous processes and reduce hold-up volume.[23][24]

Cleaning and Reuse Checks

  • To check that the membrane is clean, compare the normalized water permeability (NWP, water flux ÷ TMP) with its initial value.[18][20]
  • Sodium hydroxide (NaOH) cleaning is common, but follow the membrane manufacturer's data for concentration, temperature and time.[19][25]
  • After installing the cassette and flushing it with water, perform an integrity test before use.[19][20]

Process Condition Checklist

Item to CheckWhat to Review
MembraneMWCO (1/3 to 1/6 of the product), product retention test, format [5][7][8]
Pressure and flowOperating point set by TMP testing, rechecked at final concentration [1][2]
Buffer exchangeNumber of diavolumes, measured residual levels [9][10]
Diafiltration concentrationConcentration chosen for flux and buffer use [1][11]
Final productMeasured pH and excipients, buffer adjustment [12][14]
RecoveryHold-up and MWV, flush volume, degree of over-concentration [15][16]
ReuseNWP, cleaning conditions, integrity test [18][19][20]

Sources

  1. Merck Millipore — Ultrafiltration Learning Center: Optimization & Process Simulation
  2. Merck Millipore — A Hands-on Guide to Ultrafiltration/Diafiltration Optimization (application note)
  3. US Patent 8,840,790 — Systems and methods of controlling fouling during a filtration procedure
  4. Parker SciLog — PureTec datasheet DS-P-20
  5. Pall — What is the general rule for choosing an ultrafiltration MWCO? (FAQ)
  6. Sterlitech — What is Molecular Weight Cut-Off (MWCO)?
  7. Cytiva — Ultrafiltration technical document
  8. Merck Millipore — Ultrafiltration Learning Center: Initial Evaluation
  9. Cell and Gene Solutions — Tangential Flow Filtration (TFF): diafiltration
  10. Lorenzi et al. — Simulation of Process Performance on Contaminant Removal Using Constant and Non-Constant Volume Diafiltration Modeling, BioProcessing Journal (2016)
  11. Journal of Membrane Science (2011) — Optimal diafiltration control under the gel polarization model (abstract)
  12. BioProcess International — Accounting for the Donnan Effect in Diafiltration Optimization for High-Concentration UF/DF Applications
  13. Baek et al. — Mass balance model with Donnan equilibrium accurately describes UF/DF of monoclonal antibodies, Biotechnology Journal (2019)
  14. European patent application EP3352790A1
  15. Merck Millipore — Recovery Optimization, technical brief TB5882
  16. MilliporeSigma — Mobius TF2S performance guide PG8413
  17. Pall — Estimated Hold-up Volumes of T-Series TFF Cassettes (FAQ)
  18. MilliporeSigma — Ultrafiltration membranes, technical brief TB1502
  19. Repligen — TangenX PRO PD Cassette User Guide
  20. Pall (Cytiva) — Quick Reference: T-Series TFF Cassettes with Omega and Delta Membranes (USTR 2453b)
  21. Cell & Gene Therapy Insights — Shear ignorance? Think again: breaking the perception of shear within viral vector manufacturing
  22. Pharmaceutical Online — Toward A Gene Therapy Platform: What's The Best Format Of Tangential Flow Filtration (TFF)?
  23. American Pharmaceutical Review — Single Pass Tangential Flow Filtration for Process Intensification in Biomanufacturing
  24. Inline Protein Concentration by Vibratory Single Pass Tangential Flow Filtration (PMC open-access article)
  25. Pall — Supor Centrasette cassette validation guide USTR2439
This article is a reference summary of published regulations, standards and papers, and does not recommend any particular product. When applying it to an individual process, follow the latest original text of the relevant regulation and the review of your quality unit.
Operated by B2BIO Inc., Bioprocess Division · Report content errors to info@b2bio.co.kr

Talk to us about this topic

Tell us the topic of this article and the conditions you are working with now, and we will point you to suitable products and documents.

Talk to us about this topic
↑